Jail-based hep c cure program aims to stop virus behind bars
NCT ID NCT06953479
First seen Mar 01, 2026 · Last updated May 13, 2026 · Updated 11 times
Summary
This study tests whether a low-barrier hepatitis C treatment program can help people in jail start and finish their medication. Forty adults awaiting trial at the Rhode Island Department of Corrections will receive a 12-week course of the HCV drug Epclusa. If released early, they take the remaining doses home with support from community health workers. The goal is to cure their hepatitis C and see if this approach could be used in other jails.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C (HCV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rhode Island Department of Corrections
RECRUITINGCranston, Rhode Island, 02920, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.